Answers are grounded in this paper and cite their sources.
Dialysate calcium (DCa) and magnesium (DMg) and the organic acid used in the A (acid) concentrate have a profound combined influence on intradialytic mineral balance and may influence vascular calcification progression and treatment-related symptoms. Whereas KDIGO recommend a DCa between 1.25 (DCa 1.25) and 1.50 mmol/l (DCa 1.50), the optimal DCa for an individual patient remains uncertain. No consistent mortality difference between DCa 1.50 and 1.25 has been observed. However, DCa 1.50 may induce a positive calcium balance, raising concerns about vascular calcification progression. Conversely, DCa below 1.25 mmol/l has been associated with a higher risk of sudden cardiac death. Compared with acetic acid (Acet-D), citric-acid (Cit-D) reduces calcification propensity of serum, although the effect on vascular calcification progression is inconclusive. Whenever feasible, DCa should be individualized, ideally using estimates of calcium mass balance (CaMB). Because Cit-D generally results in a more negative CaMB than Acet-D solutions at the same nominal DCa, this difference should be considered when prescribing DCa. Increasing DMg from 0.50 to 0.75 mmol/L may improve surrogate cardiovascular outcomes although its effect on clinical outcomes remains to be defined. Overall, Acet-D with DCa 1.25 is a reasonable standard especially when using calcium containing phosphate binders and in patients at risk for adynamic bone disease, whereas in patients with a high risk of sudden cardiac death, frequent intradialytic hypotension or with severe secondary hyperparathyroidism, DCa 1.50 may be a reasonable alternative. Regarding the choice of acid, the use of Cit-D represents a promising alternative pending further clinical evidence.
No takes yet. Share an insight, caveat, or question.
Kooman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: